Clinical Trials Logo

Clinical Trial Summary

This is a prospective registry study based on a standard therapy concept for postoperative simultaneous radiochemotherapy established in Erlangen and elsewhere. The efficacy and tolerability of simultaneous postoperative radiochemotherapy is being investigated. Patients with locally advanced high-grade salivary gland carcinoma after oncological resection are admitted.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06464198
Study type Observational [Patient Registry]
Source University of Erlangen-Nürnberg Medical School
Contact Marlen Haderlein, PD Dr.
Phone 0913185
Email marlen.haderlein@uk-erlangen.de
Status Not yet recruiting
Phase
Start date July 1, 2024
Completion date June 2037